Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Splanchnic Venous Thrombosis

Hossein Akhondi  1 , Shirin Ganjali, Shivaraj Nagalli  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Splanchnic Venous Thrombosis

Hossein Akhondi et al.
Free Books & Documents

Excerpt

Abdominal veins bring blood lacking oxygen from the abdomen to the inferior vena cava, draining to the right atrium. Abdominal organs have 2 venous systems: the systemic one, which drains directly to the inferior vena cava, and the portal one, which drains to the hepatic portal vein and then to the inferior vena cava through the liver. The systemic venous system includes common iliac, lumbar, renal, right testicular/ovarian, right suprarenal, inferior phrenic, and hepatic veins. The portal venous system includes right and left gastric, cystic, para-umbilical, splenic, inferior mesenteric (via a splenic vein), and superior mesenteric vein. The splenic and superior mesenteric merge to form the portal vein. Blood clotting in these venous systems can lead to splanchnic venous thrombosis; this includes thrombosis in the splenic, mesenteric, portal, or hepatic veins (eg, Budd-Chiari syndrome). The most common site of venous thrombosis is a portal and mesenteric vein, with the least common being the hepatic vein. Splanchnic venous thrombosis can lead to different symptoms depending on the site of the thrombosis.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Hossein Akhondi declares no relevant financial relationships with ineligible companies.

Disclosure: Shirin Ganjali declares no relevant financial relationships with ineligible companies.

Disclosure: Shivaraj Nagalli declares no relevant financial relationships with ineligible companies.

References

    1. Ageno W, Riva N, Schulman S, Beyer-Westendorf J, Bang SM, Senzolo M, Grandone E, Pasca S, Di Minno MN, Duce R, Malato A, Santoro R, Poli D, Verhamme P, Martinelli I, Kamphuisen P, Oh D, D'Amico E, Becattini C, De Stefano V, Vidili G, Vaccarino A, Nardo B, Di Nisio M, Dentali F. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Intern Med. 2015 Sep;175(9):1474-80. - PubMed
    1. Acosta S, Alhadad A, Svensson P, Ekberg O. Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg. 2008 Oct;95(10):1245-51. - PubMed
    1. Fimognari FL, Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med. 2008 Sep;3(3):213-8. - PubMed
    1. Agarwal AK, Raj Kumar K, Agarwal S, Singh S. Significance of splenic vein thrombosis in chronic pancreatitis. Am J Surg. 2008 Aug;196(2):149-54. - PubMed
    1. Abu-Daff S, Abu-Daff N, Al-Shahed M. Mesenteric venous thrombosis and factors associated with mortality: a statistical analysis with five-year follow-up. J Gastrointest Surg. 2009 Jul;13(7):1245-50. - PubMed

Publication types

LinkOut - more resources